Searched for
JT MD
Amisha Vora acquires Prabhudas Lilladher Group“My mission is to ensure that we at PL continue to work towards converting our client’s savings into wealth. The PL brand has been built on...- Pankaj Renjhen Joins ANAROCK as COO & Jt. MD - ANAROCK RetailBefore joining ANAROCK, Pankaj Renjhen was COO at Virtuous Retail, where he was responsible for operations, leasing, finance & accounts, ma...
- ED arrests two former IL&FS executives in PMLA probeThe ED had registered a case under the Prevention of Money Laundering Act (PMLA) against 19 entities.
- Buy Ajanta Pharma, target Rs 1,300: Kunal BothraBuy Ajanta Pharma at a price target of Rs 1,300 and a stop loss at Rs 1,220 from entry point.
- BHEL management's commentary to decide fate of the CG stock: Dilip BhatThe management commentary on the landscape over the next three to four quarters would matter the most, says Bhat in a chat with ET Now.
- CVC probing corruption charges against IFFCO MD, Jt MDThe charges includes two illegal contracts for cornering a posh bungalow worth crores in the national capital from the society's fund.
- Valentine provides spark in sales: ArchiesIn an Interview with ET NOW, Pramod Arora, Jt MD, Archies, discusses company's scenario. Excerpts:
- Domestic market environment remains challenging: Alok Saxena, Jt. MD, Elder PharmaIn an interview with ET Now, Alok Saxena, Jt. MD, Elder Pharma, talks about the pharmaceutical sector and its market. Excerpts:
- Expect markets to remain rangebound for next 5-6 months: Raamdeo AgarwalIn an interview with ET Now, Raamdeo Agarwal, Co-Founder and Jt. MD, Motilal Oswal Securities, talks about the market movements. Excerpts:
- Growth slowdown is a big worry for market: Prabhudas LilladherAmisha Vora, Jt. MD, Prabhudas Lilladher, in a chat with ET Now, gives his views on RBI's policy and markets.
- It is a technology oriented tie-up: Amul Gabrani, VC & Jt MD, Tecpro SystemsAmul Gabrani, VC & Jt. MD, Tecpro Systems speaks to ET Now on their latest tie-up with AC-Tek.
- Steel prices may increase: P Bhattarcharya, Jt. MD, Usha MartinIn an interview with ET Now, P Bhattarcharya, Jt. MD, Usha Martin, talks about coal and steel prices as well as growth prospects of Usha Ma...
- SBI is a buy: Raamdeo Agrawal, Motilal Oswal Financial ServicesIf one wants to play safe, buy SBI because the correction is quite deep.
- Banking seems to be a winner: Raamdeo Agrawal, Motilal Oswal Financial ServicesBanking seems to be a winner post-Budget.
- Automotive segment looks to be a winner: Raamdeo Agrawal, Motilal Oswal Financial ServicesThe automotive segment, which was being hammered, looks to be a winner post-budget.
- Rice prices will remain firm, but not increase: Gurnam Arora, Jt. MD, Kohinoor FoodsIn an interview with ET Now, Gurnam Arora, Jt. MD, Kohinoor Foods, talks about the rice prices and export.
- Lower levels of Nifty around 5000 to 5100 may be seen: Dilip BhatIn a chat with ET Now, Dilip Bhat, Jt MD, Prabhudas Lilladher, talks about market moves.
- Results have been in line with expectations: Dilip BhatIn a chat with ET Now, Dilip Bhat, Jt MD, Prabhudas Lilladher, talks about overall markets trend and Q1 earnings.
- Wholesale bank lending rates may go up: Dilip BhatIn a chat with ET Now, Dilip Bhat, Jt MD, Prabhudas Lilladher, gave his views on RBI credit policy.
- ICICI Bank profits not to be impacted: Jt MDICICI Bank has asserted that its profitability trends, as reflected in Rs 728 crore profit in Q1 would not be impacted by overseas subsidia...
Load More- Buy Ajanta Pharma, target Rs 1,300: Kunal Bothra
